Composition: Sultamicillin Tosylate Dihydrate BP eq. to Sultamicillin 375mg (eq. to Sulbactam 147mg + Ampicillin 220mg) (tablets). It is a single-ingredient product built around Sultamicillin (penicillin + beta-lactamase inhibitor prodrug).
Sultamicillin is a mutual prodrug that releases ampicillin, a penicillin antibiotic, and sulbactam, a beta-lactamase inhibitor that protects ampicillin from degradation by certain beta-lactamase-producing bacteria.
SULTAVIN-375 is a prescription medicine from Aerochem Neutron's antibiotic range, for use on the prescription of a registered medical practitioner.
· Contains Sultamicillin Tosylate Dihydrate BP eq. to Sultamicillin 375mg (eq. to Sulbactam 147mg + Ampicillin 220mg)
· Sultamicillin — mutual prodrug that releases ampicillin, a penicillin antibiotic, and sulbactam, a beta-lactamase inhibitor that protects ampicillin from degradation by certain beta-lactamase-producing bacteria
· Presented as tablets
Prescription-only medicine
· Upper and lower respiratory tract infections
· Urinary tract infections
· Skin and soft-tissue infections
· Infections caused by susceptible beta-lactamase-producing organisms
· Other indications as per the approved prescribing information
Safety
· Contraindicated in patients with known hypersensitivity to any component.
· Contraindicated in patients with hypersensitivity to beta-lactam antibiotics (penicillins, cephalosporins or carbapenems); Clostridioides difficile-associated diarrhoea can occur. Ampicillin may cause rash in patients with infectious mononucleosis.
· Pregnancy and lactation: use only if the prescriber judges the benefit to outweigh the risk.
Clinical Rationale: The mechanisms and labelled uses of ampicillin and sulbactam described here follow the US prescribing information (DailyMed); antibiotic choice should follow local resistance data and the WHO AWaRe antibiotic book.
References
· DailyMed (US NLM) prescribing information – ampicillin and sulbactam: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=AMPICILLIN%20AND%20SULBACTAM
· WHO AWaRe (Access, Watch, Reserve) antibiotic book (2022): https://www.who.int/publications/i/item/9789240062382
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about SULTAVIN for professional use.